Tag: Balkman, Thad

Punish Pharma, Not Patients

The decision on Monday by an Oklahoma judge to fine Johnson & Johnson $572 million for its role in the state’s opioid crisis is only the first step in what promises to be years of complex litigation. In ruling that pharmaceutical marketing caused a “public nuisance” by increasing addiction and overdose deaths, Judge Thad Balkman […]

Read More

Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis

In the 1980s, Johnson & Johnson needed a reliable supply of opium for a popular product, Tylenol with codeine. So the health care conglomerate, better known for baby shampoo and Band-Aids, bought a business that grew and processed opium poppies in faraway Tasmania, off the coast of Australia. By 2015, at the height of the […]

Read More

McKinsey Advised Johnson & Johnson on Increasing Opioid Sales

At the global consulting firm McKinsey & Company, the rule is sacrosanct: Never publicly disclose client advice. And for the most part, adherence to that rule has served the company well. But in recent months, as government officials seek to assign blame for the opioid crisis that has strangled large parts of the nation, McKinsey’s […]

Read More